[go: up one dir, main page]

ES8305689A1 - Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol. - Google Patents

Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol.

Info

Publication number
ES8305689A1
ES8305689A1 ES514365A ES514365A ES8305689A1 ES 8305689 A1 ES8305689 A1 ES 8305689A1 ES 514365 A ES514365 A ES 514365A ES 514365 A ES514365 A ES 514365A ES 8305689 A1 ES8305689 A1 ES 8305689A1
Authority
ES
Spain
Prior art keywords
lower alkyl
propandiol
amino
procedure
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES514365A
Other languages
English (en)
Other versions
ES514365A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES514365A0 publication Critical patent/ES514365A0/es
Publication of ES8305689A1 publication Critical patent/ES8305689A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DEL 3-AMINO-1,2-PROPANDIOL, DE FORMULA (I), EN LA QUE R SIGNIFICA POLIHIDROXI-ALQUILO INFERIOR O CICLOALQUILO-ALCOXI INFERIOR-ALQUILO INFERIOR; Y ALK SIGNIFICA UN RESTO DE FORMULA: -CH -CH -, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN REALIZAR EN UN COMPUESTO DE FORMULA (II), EN LA QUE R TIENE EL SIGNIFICADO DE R O SIGNIFICA ALQUILO INFERIOR-SULFONILAMINO ENLAZADO EN LA POSICION 4; X , X , X Y X SIGNIFICAN UN SUSTITUYENTE SUSTITUIBLE POR HIDROGENO; Y ALK TIENE EL SIGNIFICADO YA INDICADO, UNA SUSTITUCION DE LOS GRUPOS X , X , X , X Y X , DISTINTOS DE HIDROGENO, POR ATOMOS DE HIDROGENO. DICHA SUSTITUCION SE REALIZA MEDIANTE SOLVOLISIS O MEDIANTE REDUCCION. DE APLICACION EN FARMACIA POR SU ACTIVIDAD BLOQUEADORA SOBRE LOS ~J-RECEPTORES ADRENERGICOS.
ES514365A 1980-08-13 1982-07-26 Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol. Expired ES8305689A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH611880 1980-08-13

Publications (2)

Publication Number Publication Date
ES514365A0 ES514365A0 (es) 1983-04-16
ES8305689A1 true ES8305689A1 (es) 1983-04-16

Family

ID=4304561

Family Applications (8)

Application Number Title Priority Date Filing Date
ES504682A Granted ES504682A0 (es) 1980-08-13 1981-08-11 Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol
ES514371A Granted ES514371A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, s-propandiol
ES514367A Expired ES8305691A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514366A Granted ES514366A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1,2-propandiol.
ES514365A Expired ES8305689A1 (es) 1980-08-13 1982-07-26 Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol.
ES514369A Expired ES8305693A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514368A Granted ES514368A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514370A Expired ES8306473A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1 2-propandiol

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES504682A Granted ES504682A0 (es) 1980-08-13 1981-08-11 Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol
ES514371A Granted ES514371A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, s-propandiol
ES514367A Expired ES8305691A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514366A Granted ES514366A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1,2-propandiol.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES514369A Expired ES8305693A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514368A Granted ES514368A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514370A Expired ES8306473A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1 2-propandiol

Country Status (17)

Country Link
EP (1) EP0045964A1 (es)
JP (1) JPS5759842A (es)
KR (1) KR840002266B1 (es)
AR (6) AR231273A1 (es)
AU (1) AU543647B2 (es)
CA (1) CA1192221A (es)
DD (3) DD202691A5 (es)
DK (1) DK358381A (es)
ES (8) ES504682A0 (es)
FI (1) FI812465L (es)
GR (1) GR74992B (es)
HU (1) HU186342B (es)
IL (1) IL63539A (es)
NO (1) NO812736L (es)
NZ (1) NZ198020A (es)
PT (1) PT73511B (es)
ZA (1) ZA815554B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58417B1 (en) * 1984-04-27 1993-09-22 Ici Plc Chemical derivatives
GB201101959D0 (en) * 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
FI791727A7 (fi) * 1978-06-05 1981-01-01 Ciba Geigy Ag Menetelmä N-alkyloitujen aminoalkoholien valmistamiseksi.
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Also Published As

Publication number Publication date
IL63539A (en) 1984-11-30
ZA815554B (en) 1982-08-25
AU543647B2 (en) 1985-04-26
ES514365A0 (es) 1983-04-16
AR231275A1 (es) 1984-10-31
ES8305694A1 (es) 1983-05-01
ES8301462A1 (es) 1982-12-01
IL63539A0 (en) 1981-11-30
PT73511B (en) 1983-07-06
ES8305690A1 (es) 1983-05-01
ES514371A0 (es) 1983-05-01
NO812736L (no) 1982-02-15
ES504682A0 (es) 1982-12-01
NZ198020A (en) 1985-04-30
AR231273A1 (es) 1984-10-31
AR231274A1 (es) 1984-10-31
ES514367A0 (es) 1983-04-16
AR229188A1 (es) 1983-06-30
AR231631A1 (es) 1985-01-31
DK358381A (da) 1982-02-14
ES8305691A1 (es) 1983-04-16
GR74992B (es) 1984-07-12
ES8305692A1 (es) 1983-05-01
FI812465A7 (fi) 1982-02-14
ES514369A0 (es) 1983-05-01
KR830006173A (ko) 1983-09-17
ES514366A0 (es) 1983-05-01
AR231278A1 (es) 1984-10-31
DD202691A5 (de) 1983-09-28
HU186342B (en) 1985-07-29
DD202286A5 (de) 1983-09-07
KR840002266B1 (ko) 1984-12-14
ES514370A0 (es) 1983-06-01
AU7402081A (en) 1982-02-18
JPS5759842A (en) 1982-04-10
PT73511A (en) 1981-09-01
DD202532A5 (de) 1983-09-21
ES8306473A1 (es) 1983-06-01
FI812465L (fi) 1982-02-14
ES8305693A1 (es) 1983-05-01
ES514368A0 (es) 1983-05-01
EP0045964A1 (de) 1982-02-17
CA1192221A (en) 1985-08-20

Similar Documents

Publication Publication Date Title
AR247721A1 (es) Un procedimiento para la preparacion de compuestos de fenetanolamina y sus sales y solvatos farmaceuticamente aceptables
ES8400444A1 (es) Procedimiento para la preparacion de nuevos derivados de carbapenem.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
ES8604964A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
ES8103752A1 (es) Procedimiento para la preparacion de acidos 3-cefem-4-carbo-xilicos sustituidos en la posicion 7
ES8507534A1 (es) Procedimiento para la preparacion de derivados benzopiranicos
PT98545A (pt) Processo para a preparacao de novos conjugados de antraciclinas utilizados como ligantes de agentes bioactivos
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
ES2029297T3 (es) Empleo de una composicion para el tratamiento de las superficies de los suelos.
ES8702437A1 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8106291A1 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
ES462006A1 (es) Procedimiento para la obtencion de nuevas feniletilaminas.
ES8404671A1 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
MX9300970A (es) Compuestos no ionicos poli-iodicos y procedimiento para su preparacion.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
MX9301404A (es) Derivados de 2-oxoquinolina, procedimiento para su preparacion, preparado farmaceutico que los contiene y procedimiento para la obtencion de tal preparado farmaceutico.
ES8305689A1 (es) Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol.
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
ES463971A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos.
MX9304820A (es) Derivados de 1, 4-benzodioxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ES8402280A1 (es) Procedimiento para la obtencion de benzofuranonas.
ES2065407T3 (es) Supresor de polen que comprende una cinolina sustituida con 5-oxi o amino.
AR241534A1 (es) Compuestos de 7-(2-(5-amino-1,2,4-tiazol-3-il)-2-alcoxiimino-acetamido)-3-metil-imidazo piridinio o imidazo-pirimidinio-3-cefem-4-carboxilato y sus sales.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991007